- Report
- January 2026
- 182 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 292 Pages
Global
From €2244EUR$2,500USD£1,957GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- February 2026
- 250 Pages
Global
From €4030EUR$4,490USD£3,515GBP
- Report
- January 2026
- 192 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 190 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 187 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 197 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 188 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP
- Report
- January 2026
- 181 Pages
Global
From €3182EUR$3,545USD£2,775GBP
€3535EUR$3,939USD£3,084GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more